2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

CMS Reclassifies EVAR and Improves Reimbursement

August 3, 2015 -- The Centers for Medicare & Medicaid Services (CMS) reclassification of endovascular abdominal aneurysm repair (EVAR) to a new Medicare Severity…

Merit Medical’s QuadraSphere Microspheres Receive Expanded Clearance for Hepatoma

August 4, 2015 -- Merit Medical Systems, Inc. announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to expand the indication for …

FDA Approves TriVascular’s Ovation iX Abdominal Stent Graft System

August 4, 2015 -- TriVascular Technologies, Inc. announced that the US Food and Drug Administration approved the company’s next-generation Ovation iX “integra…

Gynesonics’ Investigational Sonata System Receives New AMA CPT Code for Uterine Fibroids Treatment

August 4, 2015 -- Gynesonics announced that the American Medical Association (AMA) Current Procedure Terminology (CPT) Editorial Panel has established a new AMA CPT code speci…

TriVascular’s Clinical Studies of Ovation EVAR Device Reach Milestones

August 3, 2015 -- TriVascular Technologies, Inc. announced it reached milestones in two clinical trials of the company’s Ovation abdominal stent graft platform for endov…

Vascular Solutions Announces Launch of 0.035-Inch Catheters for PolarCath System

August 3, 2015 -- Vascular Solutions, Inc. announced the expansion of the PolarCath peripheral dilatation system product line with the launch of 11 versions of the 0.035-…

NDC Acquires Interface Catheter Solutions; to Become Confluent Medical Technologies

August 3, 2015 -- Nitinol Devices & Components, Inc. (NDC) announced that it has completed the acquisition of Interface Catheter Solutions (Interface). The combined compan…

Click here for more News coverage

Current Supplement

Sponsored by Endologix, Inc.

New Perspectives on Challenging AAA Necks

And why graft design matters in treating Reverse Taper Necks

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $50.51  0.02%
AstraZeneca PLC $34.34  1.18%
Boston Scientific Corporation $17.09  -0.12%
BTG plc $649.00  -0.84%
Cardiovascular Systems Inc. $29.56  2.07%
CR Bard Inc. $196.29  0.05%
Edwards Lifesciences Corp. $149.37  -1.14%
Endologix Inc. $12.01  -14.58%
Hansen Medical, Inc. $0.81  -2.40%
Vascular Market Price  Change
Johnson and Johnson $99.80  -0.22%
Lombard Medical, Inc. $4.00  8.40%
Medtronic, Inc. $77.77  -0.29%
Merit Medical Systems, Inc. $25.46  0.83%
St. Jude Medical Inc. $72.76  -0.87%
The Medicines Company $31.02  0.03%
The Spectranetics Corporation $16.51  -1.37%
TriVascular Technologies, Inc. $6.00  3.63%
Vascular Solutions Inc. $37.84  1.72%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media